PMDA: Notice (2nd ed.) on nitrosamine detection in Gastrograffin oral/enema solution
「「ガストログラフイン経口・注腸用」 ニトロソアミン化合物検出のお知らせ（第2版）」を掲載しました
Published: 2026-07-13 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
PMDA's Safety Updates page lists a government announcement titled as a notice, second edition, regarding the detection of nitrosamine compounds in Gastrograffin for oral and enema use. The item is dated 2026-07-13 and was posted as a new safety-information entry. The provided metadata does not include the content of the notice itself.
Business Impact
Manufacturers, importers, distributors, and healthcare providers handling this product may wish to check whether the notice affects product supply, quality information, or clinical use. The actual scope and any requirements are not determinable from the provided metadata.
Recommended Action
Review the official Japanese PMDA notice at the source URL to confirm its content, affected products, and any stated measures.